JUVA LIFE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0295 USD | 0.00% |
|
+36.57% | +39.15% |
| 04-10 | Juva Life Inc. Unveils New Cannabis Vape Category - Rosin Absolute | CI |
| 2023 | Juva Life Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2021 | 3.87 308.31 | Sales 2022 | 5.76 459.47 | Capitalization | 10.4M 829M |
|---|---|---|---|---|---|
| Net income 2021 | -11M -877M | Net income 2022 | -10M -797M | EV / Sales 2021 | 8,085,207 x |
| Net Debt 2021 | 1.62M 129M | Net Debt 2022 | 7.38M 588M | EV / Sales 2022 | 3,084,662 x |
| P/E ratio 2021 |
-2.51
x | P/E ratio 2022 |
-0.99
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 52.48% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | +36.57% | ||
| Current month | +47.50% | ||
| 1 month | +33.48% | ||
| 3 months | +47.50% | ||
| 6 months | +46.04% | ||
| Current year | +39.15% |
1 week
0.02
0.03
1 month
0.020.03
Current year
0.010.03
1 year
0.010.06
3 years
0.010.70
5 years
0.012.65
10 years
0.012.65
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Dan Hughes
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kari A. Gothie
ADM | Chief Administrative Officer | - | 29/05/19 |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 0.0295 | 0.00% | 25,955 |
| 01/05/24 | 0.0295 | -1.67% | 156,955 |
| 30/04/24 | 0.03 | +17.65% | 65,500 |
| 29/04/24 | 0.0255 | +20.85% | 12,820 |
| 26/04/24 | 0.0211 | -0.94% | 13,768 |
Delayed Quote OTC Markets, May 02, 2024 at 03:12 pm
More quotes
Juva Life Inc. is a Canada-based life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. The principal business of the Company is to acquire, own, and operate various cannabis businesses in the state of California. Its segments include the resale of merchandise and cannabis derived products, and cultivation and sale of trim and flowers. The Company is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and recreational cannabis users. Juva Retail is a network of retail cannabis facilities that serves the San Francisco Bay Area and other areas. It leverages revenue derived from its retail operations to advance JUVA-019, JUVA-041, and other potentially valuable non-cannabinoid bio actives for consumer and pharma product applications.
Sector
Pharmaceuticals
Calendar
23/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +39.15% | 4.84M | |
| +40.29% | 4.18B | |
| +143.80% | 2.25B | |
| +106.35% | 68.65M |
- Stock Market
- Equities
- JUVA.F Stock
